Warrants - Schedule of Warrant Activity (Details) - Warrants - $ / shares |
3 Months Ended | 11 Months Ended |
|---|---|---|
Mar. 31, 2025 |
Dec. 01, 2024 |
|
| Warrants [Line Items] | ||
| Number of Warrants, Granted | 450,000 | |
| Weighted Average Exercise Price, Granted (in Dollars per share) | $ 0.8 | |
| Number of warrants, Expired | ||
| Number of warrants, Exercised | ||
| Balance | 6,259,799 | 5,809,799 |
| Weighted Average Exercise Price, Outstanding at ending (in Dollars per share) | $ 1.16 | $ 1.19 |
| Weighted Average Remaining Contractual Term (Years), Outstanding at ending | 4 years 7 months 6 days | 4 years 9 months 25 days |
| X | ||||||||||
- Definition Represent the share based compensation arrangement by share based payment award non option equity instruments granted weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Represent the share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Represent the share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|